Transplantation, AutologousLymphoma, Large B-Cell, DiffuseHematopoietic Stem Cell TransplantationStem Cell TransplantationLymphoma, B-CellAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanLymphoma, Non-HodgkinTransplantation, HomologousTransplantation ConditioningTreatment OutcomeVincristineAntibodies, Monoclonal, Murine-DerivedCyclophosphamideCombined Modality TherapyLymphoma, FollicularRemission InductionProto-Oncogene Proteins c-bcl-6DoxorubicinPrednisoneSalvage TherapyHodgkin DiseaseStem CellsDisease-Free SurvivalGerminal CenterEtoposidePrognosisCytarabineRecurrenceRetrospective StudiesMyeloablative AgonistsLymphomaSurvival RateCarmustineSurvival AnalysisBone Marrow TransplantationHematopoietic Stem Cell MobilizationGraft vs Host DiseaseThiotepaChemotherapy-Induced Febrile NeutropeniaBone Marrow PurgingHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Mantle-CellWhole-Body IrradiationFatal OutcomeAmyloidosisHematopoietic Stem CellsDexamethasoneBoronic AcidsBusulfanB-LymphocytesPyrazinesLymphoproliferative DisordersTranslocation, GeneticGraft SurvivalFollow-Up StudiesEpstein-Barr Virus InfectionsLymphoma, B-Cell, Marginal ZoneAntineoplastic Agents, AlkylatingCARD Signaling Adaptor ProteinsAntineoplastic AgentsAntigens, CD34AutograftsIfosfamideThalidomideTime FactorsLiver TransplantationInduction ChemotherapyMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisPodophyllotoxinImmunohistochemistryTransplantation ChimeraNeoplasm, ResidualMaintenance ChemotherapyTissue DonorsLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationCell TransplantationAntibodies, MonoclonalKidney TransplantationMitoxantroneCell Line, TumorNeoplasms, Second PrimaryEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsMyelodysplastic SyndromesIdarubicinCisplatinLeukemia, Plasma CellGene Expression ProfilingProspective StudiesInfusions, SpinalTumor Markers, BiologicalImmunophenotypingDrug Administration Schedule